申请人:C.F. Boehringer & Soehne GmbH
公开号:US04070373A1
公开(公告)日:1978-01-24
Novel tricyclic aminoalkyl derivatives are disclosed which are characterized by valuable pharmacological activities and namely by cardiac and circulatory activities. The tricyclic aminoalkyl derivatives are compounds of the formula: ##STR1## wherein X is an oxygen or a sulfur atom, a saturated or unsaturated, straight chain or branched alkylene group containing up to 3 carbon atoms, an oxymethylene, thiamethylene or thiaethylene group or a valency bond, R.sub.1 is hydrogen, halogen, alkyl, alkoxy or trifluoromethyl, R.sub.2 is hydrogen or hydroxyl, R.sub.3 is hydrogen or together with R.sub.2 represents a further valency bond, R.sub.4 and R.sub.5 which may be the same or different are each hydrogen or lower alkyl, A is alkylene which is substituted by an optionally acylated hydroxyl group, Y is an oxygen or sulfur atom or an optionally alkylated imino group and Z is aryl, aralkyl, cycloalkyl or cycloalkyl-alkyl which may be substituted by halogen, hydroxyl, nitro, amino, alkoxy, aralkoxy, alkyl, trifluoromethyl, alkylamino or alkylsulfonyl group, and the acid addition salts thereof with pharmacologically acceptable acids.
本发明揭示了新型
三环氨基烷基衍
生物,其具有有价值的药理活性,特别是心脏和循环活性。该
三环氨基烷基衍
生物是以下式的化合物:##STR1##其中X是氧或
硫原子,饱和或不饱和的直链或支链烷基,含有最多3个碳原子,氧甲基,
硫甲基或
硫乙基基团或价键,R.sub.1是氢,卤素,烷基,烷氧基或三
氟甲基,R.sub.2是氢或羟基,R.sub.3是氢或与R.sub.2一起表示进一步的价键,R.sub.4和R.sub.5可以相同也可以不同,均为氢或低级烷基,A是被一个可选的酰基化羟基取代的烷基,Y是氧或
硫原子或一个可选的烷基化
亚胺基,Z是芳基,芳基烷基,环烷基或环烷基烷基,可以被卤素,羟基,硝基,
氨基,烷氧基,芳基烷氧基,烷基,三
氟甲基,烷基
氨基或烷基磺酰基基团取代,以及其与药理学上可接受的酸形成的酸加成盐。